Further, conditions such as OCD and PTSD, which were found in greater numbers in our medicated BD sample, have been associated with a reduction in amygdala volume (Szeszko et al., 1999) (Karl et al., 2006) Since our medicated BD sample had larger amygdala volumes than non-medicated BD patients or healthy controls, this suggests that if anything, the increased substance abuse and comorbidity found